Migration Mechanisms — Explain how integrins and focal adhesions support migration (conceptual)

Understanding how cells move through tissues has been one of the central problems in cell biology, with implications ranging from embryonic development to immune surveillance and cancer metastasis. For much of the twentieth century, researchers recognized that cells adhere to their environment and that this adhesion is somehow linked to locomotion, yet the molecular identities of the molecules responsible remained elusive. The discovery of integrins in the 1980s and the subsequent characterization of focal adhesions as macromolecular signaling hubs transformed our understanding of how cells generate traction and translate intracellular actin dynamics into directed movement. This section traces the key milestones that brought us from early observations of cell crawling to a sophisticated molecular model of integrin-mediated migration.

The central question that this lesson addresses is deceptively straightforward: how does a cell crawl? More precisely, how do integrins and the focal adhesion complexes they nucleate provide the traction, directionality, and regulatory signals that convert actin polymerization at the leading edge into net forward displacement of the entire cell body?

Cell migration on a two-dimensional substrate is classically described as a cyclic, multistep process. At the conceptual heart of this cycle lies the interplay between protrusion, adhesion, contraction, and detachment. Each step depends on molecular machinery in which integrins and focal adhesions play indispensable roles. Before examining these steps in detail, it is essential to establish several foundational concepts.

The diagram below illustrates the four canonical steps of mesenchymal cell migration on a two-dimensional substrate. Each step is shown in a sequential panel from left to right, highlighting the spatial distribution of integrins, focal adhesions, actin filaments, and myosin II motors. Notice how the leading edge is dominated by small, newly formed nascent adhesions, while the rear contains larger, mature focal adhesions that are under tension and primed for disassembly.

In the diagram, note that nascent adhesions (small green dots) are concentrated near the leading edge, where freshly polymerized actin pushes the membrane outward. As the cell advances and these adhesions experience increasing myosin-generated tension, they either mature into larger focal adhesions (pink rectangles) or disassemble. Mature focal adhesions serve as anchoring points for actin stress fibers, which transmit contractile force generated by myosin II motors. At the trailing edge, adhesions must be dissolved—often through calpain-mediated proteolysis of talin or integrin endocytosis—to permit tail retraction and complete the migration cycle. This spatial asymmetry of adhesion dynamics is what establishes cell polarity and enables persistent, directional movement.

The molecular events underlying integrin-mediated adhesion and migration involve a tightly regulated cascade of conformational changes, protein recruitment, and force-dependent maturation. Understanding this mechanism requires examining integrin activation, the assembly of focal adhesion scaffolds, and the feedback loops that connect adhesion to the actin cytoskeleton.

Integrin Conformational Activation

Integrins exist in three principal conformational states: a bent-closed (low affinity), extended-closed (intermediate affinity), and extended-open (high affinity) conformation. In their resting state, integrins adopt the bent-closed form, with the ligand-binding headpiece folded back toward the membrane, minimizing interaction with ECM. Inside-out signaling, triggered by intracellular signals such as talin binding to the β-integrin cytoplasmic tail, disrupts the α/β tail salt bridge and induces a switchblade-like extension that exposes the ligand-binding site. Upon engaging an ECM ligand (e.g., the RGD motif on fibronectin), the headpiece undergoes a further swing-out of the hybrid domain, fully opening the integrin and stabilizing high-affinity binding.

From Nascent Adhesion to Focal Adhesion

When activated integrins cluster and engage ECM ligands, they recruit an initial set of adaptor proteins—including paxillin, talin, and kindlin—forming nascent adhesions (~100 nm diameter, lifetime ~1 minute) within the lamellipodium. These small adhesions either turn over rapidly or, if exposed to sufficient myosin-generated force, transition into focal complexes and then into fully mature focal adhesions. During maturation, key events include: (1) recruitment of vinculin to force-unfolded talin rod domains, which cross-links the adhesion to F-actin; (2) autophosphorylation of FAK at Y397, creating a binding site for Src kinase and activating downstream Rac1 and RhoA GTPase pathways; and (3) engagement of zyxin and α-actinin, which further reinforce the actin–adhesion linkage.

Force-Dependent Maturation: The Clutch Model

The molecular clutch model provides a conceptual framework for understanding how traction forces are transmitted. In this model, F-actin flows rearward (retrograde flow) driven by both polymerization at the leading edge and myosin II contraction. Focal adhesion proteins act as a clutch that couples this actin flow to stationary integrins attached to the ECM. When the clutch is engaged, actin flow is slowed and its energy is converted into forward protrusion. When the clutch disengages (adhesion is weak), actin slips rearward unproductively. The efficiency of the clutch—and therefore migration speed—depends on the number and stiffness of adhesion bonds, the rate of actin flow, and the rigidity of the substrate.

Super-resolution imaging studies, particularly those using interferometric photoactivated localization microscopy (iPALM), have revealed that focal adhesions possess a remarkably organized vertically stratified architecture. Proteins within a focal adhesion are not randomly distributed but are organized into three functional layers spanning approximately 40 nm between the plasma membrane and the actin cytoskeleton. Understanding this architecture is crucial for appreciating how force is transmitted through the adhesion complex and how signaling is spatially compartmentalized.

Consider a fibroblast migrating on a fibronectin-coated surface toward a chemoattractant gradient (e.g., PDGF). We will trace the molecular events at a single point on the leading edge from initial protrusion to tail retraction, identifying where integrins and focal adhesions participate at each stage.

The relationship between adhesion strength and migration speed is not linear; rather, it follows a biphasic (bell-shaped) curve. At very low adhesion, cells cannot generate sufficient traction and migration is slow. At very high adhesion, cells become essentially immobilized because trailing-edge detachment becomes rate-limiting. Maximum migration speed occurs at an intermediate, optimal level of adhesion. This principle has profound implications for understanding how different cell types, ECM compositions, and integrin expression levels influence migratory behavior in health and disease.

The integrin–focal adhesion paradigm described in this lesson applies most directly to mesenchymal migration—the slow, adhesion-dependent, protease-assisted mode used by fibroblasts, endothelial cells, and many epithelial-derived cancer cells undergoing EMT. However, cells can migrate through alternative mechanisms that reduce or eliminate their dependence on integrin-mediated adhesion. Understanding how the classical model connects to these advanced modes is essential for a complete picture of cell motility.

A clinically significant phenomenon is the mesenchymal-to-amoeboid transition (MAT), in which cancer cells treated with MMP inhibitors or subjected to confinement switch from focal adhesion-dependent mesenchymal migration to an integrin-independent, RhoA/ROCK-driven amoeboid mode. This plasticity means that targeting integrins or focal adhesions alone may be insufficient to prevent metastasis, as cancer cells can escape through alternative migration strategies. Current research aims to identify the molecular switches governing this transition and to develop combination therapies that block both migration modes simultaneously.